We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
1st question, Cameron, Is this just a repeat of Astop Biohealth "The float that never was" ?
Parry declines to comment on the details of the loan agreements between Surepoint and the private individuals signed in 2002. "Because Surepoint is a private company, we do various arrangements with private people," he says.
According to the loan agreements seen by the AFR, the funds are repayable, with 10 per cent annual interest, only on the successful public listing of Astop, and can also be converted into shares upon listing.
Also waiting patiently for a listing are about 700 shareholders in listed Perth-based mining company West Australian Metals, who sank a combined $1 million into Astop in a raising last year and have the right to subscribe for up to 50 per cent of the shares in a float.
In a reminder that he has lost none of his trademark salesmanship, Parry told those investors in an information statement for the capital raising last year: "I am of the belief that we have a product which has a world impact potential and I look forward to the company being able to help millions of people who suffer from breathing and related problems."
He also said that the domestic market for anti-asthma products was worth about $650 million and was growing at 12.5 per cent a year.
Cameron Parry, 32, who is now the chief executive of Astop, says he has engaged Melbourne-based Domain Capital to handle the float and that Astop will be seeking to raise $7 million by May next year. The funds will be spent on overseas marketing and establishing a distribution hub in Singapore to export the product.
Parry says a pre-IPO this month will also raise $2 million that will be spent on "aggressive" marketing. But the Australian Stock Exchange listing will occur only if Astop Biohealth is cash flow positive. "We will assess our sales figures in March and then release a prospectus," he says.
Parry says Astop will be distributed nationally, through a deal with 4800 pharmacies, and has already found its way into "a couple of hundred pharmacies" after its recent return to commercial sales.
He defends the long wait for a listing by citing the factory fire and the need to conduct broad-based clinical trials.
5 mins..
5...Are you planning to change YOUR name with any future ventures...?
End of Q&A
4 mins...
3... Are you planning to move out of the country?
4... Will you change your identity?
Rns supposed to be released today before the q&a
Probably got nothing to say
i see Mr Parry was not brave enough to release the RNS ahead of the shareholder Q&A tonight so that it may be discussed fully.
not that the Q&A needs an hour.
all done with in 2 minutes.
1.. crowdfunding, when ?
2... relisting, when ?
end of Q&A
no problem BB
Lets hope gold has a sustained rally .
be safe .
Wow Stix....Imagine that....Definately can't rule it out if thing in the markets get worse.
I just copied in to the GGP board hope you don't mind.
https://cryptopotato.com/analysis-gold-price-should-be-8900-5x-higher-and-here-is-why/?amp
Plenty of ranting on here lately ,
Looks like Q&A going ahead on Monday , I guess the question of business effect from the virus will come up , as all investors have hard earned dosh in here a clarification of forward plan/ relist with dates would be the minimum expected .
Do rate the product & use it when not in lockdown for the odd bottle of Rum .